Fig. 38From: Molecular docking studies of coumarin hybrids as potential acetylcholinesterase, butyrylcholinesterase, monoamine oxidase A/B and β-amyloid inhibitors for Alzheimer’s diseaseCoumarin alkylamines C41i–C41l (entry 9–12)Back to article page